Moreover, Colorectal cancer stemness and oxaliplatin resistance are induced by CPT2 downregulation, which potentiates glycolytic metabolism mediated by ROS/Wnt/β-Catenin pathways (Li et al., 2021). The gene discussed is CPT2; the disease is colorectal cancer.